We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Innovative Sensor Traces Signature of Human Heartbeat

By HospiMedica International staff writers
Posted on 26 Oct 2010
A miniature magnetic sensor has been used to detect the faint magnetic signature of a human heartbeat successfully, confirming the device's potential for biomedical applications. More...


Researchers from the U.S. National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA) and the German National Metrology Institute (PTB; Berlin, Germany) have micro-fabricated chip-scale atomic magnetometers (CSAMs)--consisting of a container with about 100 billion rubidium atoms in gas form, a low-power infrared laser, and optics--that are capable of detecting faint magnetic fields. The devices, about one square centimeter in size, were taken to the PTB, which possesses the most magnetically isolated building in the world. Using the tiny magnetometers, the investigators were able to detect the magnetic signature of human heartbeats, as measured in picoteslas (pT), perhaps opening up the possibility for a new modality to complement electrocardiograms (ECGs).

In the experiments at PTB, a sensor was placed 5 millimeters above the left side of a person lying face up. The sensor successfully detected the weak but regular magnetic pattern of the heartbeat. The signals were also recorded using a superconducting quantum interference device (SQUID), the current "gold standard" for magnetic measurements, and a comparison between the two signals confirmed that the minisensor correctly measured the heartbeat and identified many typical signal features. While the CSAM generated more signal interference, it works at room temperature, whereas the SQUID device works work best at -269 °C, and requires more complicated and expensive supporting apparatus. The study describing the CSAM sensor and the experiment were published early online on September 28, 2010, in Applied Physics Letters.

The study also demonstrated that atomic magnetometers could offer sensing stability lasting tens of seconds, as needed for an emerging technique called magnetorelaxometry (MRX), used to localize, quantify, and image magnetic nanoparticles inserted into biological tissue for medical applications such as targeted drug treatments.

Related Links:
U.S. National Institute of Standards and Technology
German National Metrology Institute


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.